2025-12-07 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the data provided, broken down into sections as requested:

**1) Return Rate Comparison & Analysis**

*   **Company Overview:** Procter & Gamble (PG) is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.
*   **Return Rate Comparison:**
    *   PG Cumulative Return: 28.09%
    *   S&P 500 (VOO) Cumulative Return: 100.58%
    *   Divergence: -72.3
    *   Relative Divergence: 1.7

*   **Analysis:**
    *   PG has significantly underperformed the S&P 500 over the measured period. The divergence of -72.3 indicates a substantial difference in cumulative returns.
    *   The relative divergence of 1.7 suggests that the current divergence is near the bottom end of its historical range. This could mean that the underperformance is particularly pronounced *right now*.

*   **Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%    | 0.0    | 210.3  |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%    | 0.1    | 210.4  |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%     | 0.3    | 285.8  |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%     | 0.4    | 318.4  |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%    | 0.5    | 374.4  |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%    | 0.6    | 346.8  |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%    | 0.4    | 335.4  |
| 2022-2024  | 9.0%    | 79.4%   | -12.0%   | 0.4    | 383.7  |
| 2023-2025  | -16.0%  | 80.1%   | -81.0%   | 0.2    | 335.7  |

*   **Analysis:**
    *   **CAGR:** The Compound Annual Growth Rate (CAGR) shows varied performance across different periods.  The most recent period (2023-2025) shows a significant negative CAGR of -16.0%.
    *   **MDD:**  The Maximum Drawdown (MDD) has been quite high in recent periods, indicating significant potential for losses from peak to trough.
    *   **Alpha:** Alpha measures the investment's performance relative to the market (S&P 500). Negative alpha values (especially the recent -81.0%) suggest underperformance compared to the market. Positive alpha values indicate outperformance.
    *   **Beta:** Beta measures the investment's volatility relative to the market. A beta around 0.0-0.6 suggests PG has been less volatile than the S&P 500 in general, meaning it tends to move less than the market.
    *   **Cap(B):** The market capitalization is in Billions of dollars.

**2) Recent Stock Price Fluctuations**

*   Close Price: 146.71
*   Last Market Data: Price: 143.45, Previous Close: 145.36, Change: -1.31
*   5-day SMA: 147.05
*   20-day SMA: 147.31
*   60-day SMA: 150.67

*   **Analysis:**
    *   The stock price closed at 146.71, with a last market price of 143.45 (a further decrease).
    *   The 5-day and 20-day SMAs are very close to each other but below the 60-day SMA. This suggests a short-term downtrend as the recent price action is below the longer-term average.
    *   The negative change in the last market data suggests continued downward pressure.

**3) RSI, PPO, and Divergence Analysis**

*   Market Risk Indicator (MRI): 0.8 (Medium Investment Recommended)
*   RSI: 46.07
*   PPO: 0.024
*   Hybrid Signal: "cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)"
*   Recent (20 days) relative divergence change: -9.2 (Short-term decline)
*   Expected Return (%): 52.9

*   **Analysis:**
    *   **MRI:** The MRI of 0.8 suggests a medium investment recommendation, indicating a moderate level of risk.
    *   **RSI:** An RSI of 46.07 is neutral, neither overbought nor oversold.
    *   **PPO:** A PPO of 0.024 indicates that the short-term moving average is slightly above the long-term moving average, which could be a weak bullish signal, but very slight.
    *   **Hybrid Signal:** Despite the recent price decline, the hybrid signal recommends buying, indicating confidence in the long-term stability of the stock, based on its "Very Safe" designation and a high MRI score.
    *   **Recent Divergence Change:** The negative change in relative divergence confirms a short-term downward trend, aligning with the SMA analysis.
    *   **Expected Return:** The high expected return (52.9%) suggests that the system believes the stock is currently undervalued and has significant upside potential over a 2-year timeframe, relative to the S&P 500.

**4) Recent News & Significant Events**

*   Several news articles highlight concerns regarding Procter & Gamble's stock performance:
    *   "Why Procter & Gamble Stock Hit a 2-Year Low on Tuesday"
    *   "Procter & Gamble (PG) Stock Drops Despite Market Gains"
    *   "Procter & Gamble’s (PG) at a “Real Low,” Says Jim Cramer"
    *   "Procter & Gamble Stock Drops. Its CFO Says Consumers Are Nervous."
    *   "Procter & Gamble (PG) Stock: Shares Hit 52-Week Low as CFO Warns of Volatile U.S. Market"

*   **Analysis:**
    *   The news sentiment is largely negative. The recurring themes are that the stock is at a low, underperforming the market, and that there are concerns about consumer behavior affecting P&G's performance. The CFO's warning adds weight to these concerns.

**4-2) Analyst Opinions**

*   **Consensus:**
    *   Rating: Buy
    *   Mean Rating: 2.00 (Buy)
    *   Opinions: 22
    *   Target Price (avg/high/low): 169.05 / 186.00 / 148.00
*   **Recent Rating Changes:** No changes were provided.

*   **Analysis:**
    *   Despite the recent negative news and price action, the overall analyst consensus remains a "Buy" with a mean rating of 2.00.
    *   The average target price of $169.05 suggests a significant upside potential from the current price ($143.45), indicating that analysts believe the stock is undervalued.
    *   The high target price of $186.00 shows that some analysts are even more optimistic about the stock's potential.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-24 | 2    | 22.39 B$  |
| 2025-04-24 | 1.58 | 19.78 B$  |
| 2025-01-22 | 1.94 | 21.88 B$  |
| 2024-10-18 | 1.65 | 21.74 B$  |
| 2025-10-24 | 1.65 | 21.74 B$  |

*   **Analysis:**
    *   The table is slightly duplicated. Corrected to show all unique data.
| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-24 | 2    | 22.39 B$  |
| 2025-04-24 | 1.58 | 19.78 B$  |
| 2025-01-22 | 1.94 | 21.88 B$  |
| 2024-10-18 | 1.65 | 21.74 B$  |
    *   The EPS (Earnings Per Share) and Revenue show variability. The most recent quarter (2025-10-24) shows the highest EPS, but revenue has fluctuated.
    *   It's essential to consider this in context of the overall economic climate and consumer spending habits.

**6) Financial Information**

Revenue and Profitability:

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-09-30 | $22.39B   | 51.37%        |
| 2025-06-30 | $20.89B   | 49.11%        |
| 2025-03-31 | $19.78B   | 50.98%        |
| 2024-12-31 | $21.88B   | 52.39%        |
| 2024-09-30 | $21.74B   | 52.06%        |

Capital and Profitability:

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-09-30 | $53.27B   | 8.92%   |
| 2025-06-30 | $52.01B   | 6.95%   |
| 2025-03-31 | $52.27B   | 7.21%   |
| 2024-12-31 | $51.17B   | 9.05%   |
| 2024-09-30 | $51.84B   | 7.64%   |

*   **Analysis:**
    *   **Revenue and Profitability:** Revenue has fluctuated across the quarters, but the most recent quarter shows the highest revenue. Profit margins have remained relatively stable, generally above 50%, indicating good efficiency.
    *   **Capital and Profitability:** Equity has gradually increased over the period. ROE (Return on Equity) has also fluctuated, with the highest value in Q4 2024 and a solid performance in the most recent quarter (2025-09-30). The ROE indicates how efficiently the company is using shareholder equity to generate profits.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** PG has significantly underperformed the S&P 500, and recent news highlights investor concerns, reflected in the stock hitting a 2-year low.
*   **Short-Term Downtrend:** The short-term moving averages are below the long-term average, indicating a downtrend, and recent divergence change also confirms this.
*   **Analyst Optimism:** Despite the negative news, analysts maintain a "Buy" rating and see significant upside potential, suggesting the stock is undervalued.
*   **Financial Stability:** P&G remains a financially stable company with strong profit margins and a healthy ROE. The Hybrid signal also says the stock is very safe to buy.
*   **Mixed Signals:** The investment picture is mixed. While the stock is facing short-term headwinds and underperforming the market, analysts and the Hybrid signal suggest long-term value.

**Conclusion & Recommendation**

Based on the provided information, investing in PG is a complex decision. There are clearly short-term risks and negative sentiment. However, the strong analyst consensus, high expected return (over a longer timeframe), the financial stability of the company, and the Hybrid signal's safety rating suggest that the current price may present a buying opportunity for long-term investors who are comfortable with some short-term volatility and underperformance relative to the broader market.

*   **For a risk-averse investor:**  Consider a smaller allocation or wait for more positive news before investing.
*   **For a long-term, value-oriented investor:** The current situation may be an opportunity to buy a fundamentally sound company at a discounted price.

It is crucial to do further research and consider your personal investment goals and risk tolerance before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.